3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow RO7017773: new trials by email Literature Review of RO7017773 trials Research Report on RO7017773
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) Placebo, RO7017773 - Autism Spectrum Disorder (ASD) | Phase 2 | Completed | Hoffmann-La Roche | 104 | 2021-03-31 | 2025-01-28 |
| A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants RO7017773, Itraconazole - Healthy Volunteers | Phase 1 | Completed | Hoffmann-La Roche | 14 | 2018-12-17 | 2020-05-07 |
| Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 RO7017773, [11C] Ro15-4513 - Autism Spectrum Disorder | Phase 1 | Completed | Hoffmann-La Roche | 6 | 2018-04-24 | 2019-09-30 |
Canada (1) · France (1) · Italy (1) · Spain (1) · United Kingdom (1) · United States (1)
2018 (1), 2019 (1)